<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="helma.xsl"?>
<xmlroot xmlns:hop="http://www.helma.org/docs/guide/features/database">
  <hopobject id="2432" name="Page" prototype="Page" created="1363280116832" lastModified="1543278354621">
  <hop:parent idref="0" prototyperef="Root"/>
    <http_browser>Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1)</http_browser>
    <lang>en-us</lang>
    <uri>bone-update</uri>
    <http_host>127.0.0.1:8080</http_host>
    <time type="date">27.11.2018 00:25:54 UTC</time>
    <pseudoparent idref="0" prototyperef="Root"/>
    <http_remotehost>127.0.0.1</http_remotehost>
    <hopsession>127.0.0.cgetsv6gvimt</hopsession>
    <user>default</user>
    <pvcount type="float">85.0</pvcount>
    <body>An accountancy practice &lt;a href=&quot;https://www.greenlam.com/index.php/stmap_77410.html?viagra.asendin.uroxatral.fildena&quot;&gt;project baseline document template&lt;/a&gt;  But doctors and activists say advocating that a bad drug should continue to be used by the world&amp;#39;s poorer patients is unethical. Writing in the March 2012 issue of the Southern African Journal of HIV Medicine, the authors from the HIV-advocacy group Treatment Action Campaign, MSF, and other organisations say that the WHO&amp;#39;s suggestion to move towards tenofovir-based treatment is &quot;an important step towards bringing treatment in poor countries in line with rich ones [save for rare exceptions, d4T is no longer used in the United States and Europe, with the US removing it from the preferred list of first-line therapies in 2004]&quot;.
 </body>
    <http_language>en-US,en;q=0.8</http_language>
    <is_xhtml type="boolean">true</is_xhtml>
    <http_referer>http://beagleboard.org/bone-update/edit</http_referer>
  </hopobject>
</xmlroot>
